QI
RGEN icon

QS Investors’s Repligen RGEN Stock Holding History

QS Investors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$204K Buy
+1,020
New +$198K ﹤0.01% 1063
2021
Q1 		– Sell
-3,280
Closed -$629K – 1240
2020
Q4 		$629K Buy
3,280
+120
+4% +$21.8K 0.01% 672
2020
Q3 		$467K Sell
3,160
-21,140
-87% -$3.02M 0.01% 729
2020
Q2 		$3M Sell
24,300
-50
-0.2% -$5.88K 0.04% 346
2020
Q1 		$2.35M Buy
24,350
+23,450
+2,606% +$2.26M 0.04% 363
2019
Q4 		$85K Hold
900
– – ﹤0.01% 1417
2019
Q3 		$70K Hold
900
– – ﹤0.01% 1445
2019
Q2 		$78K Hold
900
– – ﹤0.01% 1444
2019
Q1 		$54K Sell
900
-1,900
-68% -$109K ﹤0.01% 1494
2018
Q4 		$148K Hold
2,800
– – ﹤0.01% 1222
2018
Q3 		$155K Sell
2,800
-142,259
-98% -$7.33M ﹤0.01% 1278
2018
Q2 		$6.82M Sell
145,059
-1,550
-1% -$63.8K 0.07% 201
2018
Q1 		$5.3M Sell
146,609
-10,974
-7% -$386K 0.05% 243
2017
Q4 		$5.72M Sell
157,583
-3,367
-2% -$122K 0.05% 255
2017
Q3 		$6.17M Sell
160,950
-3,864
-2% -$162K 0.05% 241
2017
Q2 		$6.83M Buy
164,814
+5,600
+4% +$213K 0.06% 211
2017
Q1 		$5.6M Hold
159,214
– – 0.05% 259
2016
Q4 		$4.91M Hold
159,214
– – 0.04% 346
2016
Q3 		$4.81M Hold
159,214
– – 0.04% 384
2016
Q2 		$4.36M Sell
159,214
-13
-0% -$332 0.04% 423
2016
Q1 		$4.27M Buy
159,227
+13
+0% +$318 0.04% 445
2015
Q4 		$4.5M Sell
159,214
-1,640
-1% -$47.3K 0.04% 427
2015
Q3 		$4.48M Sell
160,854
-70,924
-31% -$2.56M 0.05% 392
2015
Q2 		$9.56M Sell
231,778
-3,138
-1% -$115K 0.12% 216
2015
Q1 		$7.13M Hold
234,916
– – 0.08% 278
2014
Q4 		$4.65M Buy
+234,916
New +$5.25M 0.05% 376
2014
Q3 		– Sell
-36,800
Closed -$839K – 783
2014
Q2 		$839K Buy
+36,800
New +$655K 0.02% 410

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

QS Investors's RGEN Position: Q2 2021 in Review

QS Investors opened a new position in Repligen (RGEN) in Q2 2021: 1,020 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1063 among its holdings. This is a return to the name: QS Investors previously reported a position in RGEN as recently as Q4 2020.

QS Investors first reported a position in RGEN in Q2 2014 and has held it in 27 quarters since. The position peaked at $9.56M in Q2 2015. 428 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • QS Investors held 1,020 shares of Repligen worth $204K as of Q2 2021.
  • Repligen was a new QS Investors position in Q2 2021.
  • Repligen made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #1063 holding.
  • QS Investors first reported a position in Repligen in Q2 2014 and has held it in 27 quarters since.
  • QS Investors's Repligen position peaked at $9.56M in Q2 2015.
  • 428 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.